Carcinoma in Situ
7 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
Carcinoma in Situ| Treatment and condition | Where it stands | Trials |
|---|
| Biospecimen Collection + Mammography + Questionnaire Administration + Random Periareolar Fine-Needle Aspiration + TAMOXIFEN for carcinoma, intraductal, noninfiltrating | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Biospecimen Collection + Mammography + Questionnaire Administration + Random Periareolar Fine-Needle Aspiration + TAMOXIFEN + OMEGA-3-ACID ETHYL ESTERS for carcinoma, intraductal, noninfiltrating | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Breast Radiotherapy for carcinoma, intraductal, noninfiltrating | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Core Biopsy + Questionnaire Administration + AFIMOXIFENE for carcinoma, intraductal, noninfiltrating | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Nutritional Assessment + Short-Term Fasting + Metformin hydrochloride for carcinoma, intraductal, noninfiltrating | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| OK-432 for carcinoma in situ | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 4 |
|---|
| Tamoxifen for carcinoma, intraductal, noninfiltrating | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|